Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction.
- DOI
- 10.3390/pharmaceutics15020322
- Published
- 2023 Jan 18
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics15020322,
title = {Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction.},
author = {Chadderton N and Palfi A and Maloney DM and Carrigan M and Finnegan LK and Hanlon KS and Shortall C and O'Reilly M and Humphries P and Cassidy L and Kenna PF and Millington-Ward S and Farrar GJ},
year = {2023},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics15020322},
url = {https://doi.org/10.3390/pharmaceutics15020322}
}RIS
TY - JOUR TI - Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction. AU - Chadderton N AU - Palfi A AU - Maloney DM AU - Carrigan M AU - Finnegan LK AU - Hanlon KS AU - Shortall C AU - O'Reilly M AU - Humphries P AU - Cassidy L AU - Kenna PF AU - Millington-Ward S AU - Farrar GJ PY - 2023 JO - Pharmaceutics DO - 10.3390/pharmaceutics15020322 UR - https://doi.org/10.3390/pharmaceutics15020322 ER -
APA
N, C., A, P., DM, M., M, C., LK, F., KS, H., C, S., M, O., P, H., L, C., PF, K., S, M., & GJ, F. (2023). Optimisation of AAV-NDI1 Significantly Enhances Its Therapeutic Value for Correcting Retinal Mitochondrial Dysfunction.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics15020322